Rare diseases
Investigational molecules
Locations
Back to France151 clinical trials in Toulon, France across 1 research site. Every trial is listed in the EU Clinical Trials Register and updated daily.
Our site in FranceEssaisCliniques.fr(opens in a new tab)Study of Rocatinlimab Treatment for Adults and Adolescents with Moderate to Severe Atopic Dermatitis
FranceEvaluation of Ziltivekimab in Patients with Heart Failure with Mildly Reduced or Preserved Ejection Fraction and Systemic Inflammation
FranceStudy of Durvalumab and Chemotherapy for Patients with Resectable Non-Small Cell Lung Cancer
FranceStudy on Asundexian for Preventing Ischemic Stroke in Adults After a Stroke or High-Risk Mini-Stroke
FranceEfficacy and Safety of Tirzepatide Versus Placebo in Adults with Type 1 Diabetes and Obesity or Overweight: A Phase 3 Randomized Controlled Trial
FranceEfficacy and Safety Evaluation of Tulisokibart in Moderate to Severe Hidradenitis Suppurativa: A Phase 2b Randomized, Double-Blind, Placebo-Controlled Trial
FranceStudy of Rocatinlimab with Topical Treatments for Adults with Moderate to Severe Atopic Dermatitis
FranceStudy of tarlatamab with durvalumab, carboplatin and etoposide versus standard treatment in patients with previously untreated extensive stage small cell lung cancer
FranceStudy of Ivonescimab for Treating Relapsed Pleural Mesothelioma in Patients After Immunotherapy and Chemotherapy
FranceStudy Comparing Acasunlimab and Pembrolizumab with Docetaxel for Patients with Metastatic Non-Small Cell Lung Cancer After Previous Treatments
FranceStudy on Continuing Nivolumab and Ipilimumab Treatment vs. Observation in Patients with Stage IV Non-Small Cell Lung Cancer
FranceStudy of Atezolizumab, Carboplatin, and Paclitaxel for Elderly Patients with Advanced Non-Small Cell Lung Cancer
FranceThe busiest research cities in the country
What the registry says about research in the country
Extensive clinical trials focusing on non-small cell lung cancer treatments, including innovative combination therapies and immunotherapy approaches. Multiple studies evaluating novel drug combinations to improve patient outcomes.
Research spans various disease stages and includes both early-stage and metastatic cancer treatments.
Studies investigating treatments for chronic lymphocytic leukemia and blood-related conditions. Research includes evaluation of novel drug combinations and targeted therapies.
Focus on improving treatment outcomes for previously untreated patients with coexisting conditions.
Investigations into stroke prevention and treatment of thrombotic conditions. Studies evaluating new anticoagulants and therapeutic approaches for various cardiovascular conditions.
Clinical trials examining innovative treatments for atrial fibrillation and deep vein thrombosis.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
